other
NMN tracker
Educational reference for NMN. Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
—
Tmax
—
Category
other
Also known as: nicotinamide-mononucleotide
NMN (nicotinamide mononucleotide) is an NAD+ precursor used as a longevity supplement. Not a drug; supplement use.
Mechanism
Nicotinamide mononucleotide (NMN) is a NAD+ precursor. In preclinical research, supplying NMN is associated with raising NAD+ levels and supporting NAD+-dependent processes; the extent and clinical relevance in humans are still being studied.
Research summary
Preclinical studies suggest metabolic effects, and some small human trials have examined tolerability and biomarkers. Clinical outcome evidence is still developing, and its regulatory status as a supplement has been subject to change in some jurisdictions. It is not an approved drug for specific indications.
Reported side effects
Small trials have generally reported good tolerability, but long-term human safety data are limited.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- NMN human tolerability and biomarker studies · peer-reviewed clinical studies (2021)search PubMed for NMN human trial
- NAD+ precursor review · peer-reviewed review article (2020)class context; clinical outcomes still developing
TrackPep은 기록용 앱입니다. 사용자가 입력한 내용만 기록하며, 투여량을 추천하거나 계산하지 않습니다.